Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS – Get Free Report) was the target of a significant decrease in short interest in the month of May. As of May 29th, there was short interest totaling 7,566 shares, a decrease of 56.9% from the May 14th total of 17,566 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 10,000 shares, the short-interest ratio is presently 0.8 days.
Lotus Pharmaceuticals Price Performance
Shares of LTUS traded down $0.00 on Friday, hitting $0.00. 28,000 shares of the stock traded hands, compared to its average volume of 3,863. Lotus Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.01.
About Lotus Pharmaceuticals
Lotus Pharmaceuticals, trading under the symbol LTUS on the OTC Market, is a Taiwan-based pharmaceutical company specializing in the research, development, manufacturing and marketing of prescription medications. The company’s core operations encompass both the production of a broad range of generic drugs and the advancement of novel compounds aimed at therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases and anti-infective treatments.
Lotus Pharmaceuticals offers multiple dosage forms, including tablets, capsules, injectables and sterile preparations, to meet the needs of hospital and retail pharmacy channels.
Featured Articles
- Five stocks we like better than Lotus Pharmaceuticals
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for Lotus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lotus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
